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Objective. To find out the success rate of conservativemanagement of complete twoweeks formiscarriage in view ofNICEGuideline
154. Design. Prospective observational study. Setting. Early pregnancy assessment units of District General Hospital in the United
Kingdom. Participants. Women of less than 14 weeks’ gestation, with a diagnosis of miscarriage (missed miscarriage/anembryonic
or incomplete miscarriage). Interventions. Expectant management for two weeks. Main Outcome Measure. (1) Efficacy of 2-week
expectant management, that is, complete resolution of miscarriage based either on self-reporting of patient after passing products
of conception at home between D0 and D14 of expectant management or confirmation on scan at D14, and (2) short-term
complications needing strong analgesia, blood transfusion, and antibiotics. Results. Expectant management of miscarriage for 2
weeks from the day of diagnosis was successful in 58% (64 /111) and failed in 42% (47/111). Conclusions. Expectant management
success rate is consistent with the results from the longitudinal studies and RCTs published in the past. It is a safe option as none of
the patients on expectant/medical management needed strong analgesia/antibiotics or blood transfusion.
1. Introduction
Approximately 11–15% [1] of pregnancies result in sponta-
neous first-trimester miscarriage and for some women, it
could be quite traumatic experience physically as well as
psychologically. Many women want to get over it and there-
fore are quite keen on active management; either medical or
surgical; however, a sizeable percentage seems keen to explore
conservative option of wait-and-see approach.ThenewNICE
154 Guideline recommends expectant management for 7–14
days as the first-line management strategy for miscarriage
to explore management options other than expectant man-
agement if the woman is at increased risk of haemorrhage
and had history of stillbirth, miscarriage, or ante partum
haemorrhage in previous pregnancy; for example, a history
of stillbirth, miscarriage or ante partum haemorrhage in
previous pregnancy; coagulopathies; unable to have a blood
transfusion or if there is evidence of infection. We aimed
to find out the success rate of conservative management of
complete two weeks for miscarriage.
2. Material and Method
We conducted this prospective longitudinal study from
August 2012 to June 2013 in District General Hospital setting.
The NICE Guideline 154 was published in December 2012;
however, we started collecting data in our Early Pregnancy
Assessment Unit (EPAU) for this study since August 2012
when the draft version of NICE Guideline 154 was available
online. Over a ten months period, 130 cases were diagnosed
as missed miscarriage, out of which 111 agreed for expectant
management after counselling. We categorised miscarriage
based on the ultrasound finding into missed miscarriage
(MMC)/anembryonic pregnancy and incomplete miscar-
riage. For accuracy and uniformity, we calculated gestation
by ultrasound measurements as well rather than from last
menstrual period alone. We advised patients to inform us if
they thought they had a completed miscarriage by noticing
resolution of symptoms while being in the community before
two weeks and were further instructed to do urine pregnancy
test in two to three weeks’ time. However if the process of
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miscarriage has not started or they had significant vaginal
bleeding in that time period, a follow-up ultrasound scan was
arranged in EPAU.
3. Outcome Measures
(1) Expected Outcome. The Outcome of expectant manage-
ment was categorised as follows;
(a) complete resolution of vaginal bleed after passage of
products at home: the patients were instructed “what
to expect” (may notice clots with some tissue);
(b) negative pregnancy tests by the end of two weeks of
conservativemanagement if RPOCpassedwithin this
time.;
(c) we expected either no retained products of concep-
tion on ultrasound scan if patient is scheduled for the
pelvic scan appointment on D14 or RPOCs less than
2 cm (no intervention was undertaken if there is no
history of heavy bleeding).
(2) Short-Term Complications. Following were regarded as
complication for the purpose of our study, that is, the need
for strong (opiate) analgesia, evidence of infection requiring
antibiotics, or heavy vaginal bleeding required blood transfu-
sion due to hemodynamic instability.
4. Results
In this study, we found that 20% women were <25 years, 39%
aged between 25 and 30 years, whereas 41% were 31–46 years
of age. 45% were primiparous and multiparous found to be
55%.Our study revealed that 71% of (79/111) pregnancies were
<9 weeks, whereas 27% (30/111) were 9–12 weeks of gestation
and only 2 patients were found to be >12 weeks of gestation.
The 95% cases were diagnosed as MMC and incomplete
miscarriage in 5% cases based on ultrasound findings. After
accepting conservative management for two weeks (which
started from the day of ultrasound diagnosis of miscarriage),
we found it to be successful in 58% (64/111) cases while being
unsuccessful in 42% (47/111). In the successful group, 17%
(11/64) weremanaged at community level that did not require
a follow-up at EPAU or a scan. However 50 patients of this
study attended follow-up to our EPAU and were triaged by
assessments of symptoms and urine test for pregnancy. The
patients with minimal symptoms and negative pregnancy
test (22/64 = 34%) were discharged from EPAU without a
scan. Therefore 51% of successful conservative management
group did not require a pelvic scan. The 28 (43%) patients
of this group had a scan, dictated by symptoms or positive
test for pregnancy or both, were found to have complete
miscarriage or RPOC less than 2 cm, and therefore as per
our study protocol were discharged home. The three patients
were admitted due to significant vaginal bleeding and passed
RPOC in the hospital and later scan confirmed complete
miscarriage.
Out of the unsuccessful group, 27 patients opted for
surgical management and the remaining 20/47 chosemedical
management. The patients who accepted medical manage-
ment received 800mcg of misoprostol as loading dose and
6 hours later had 400mcg PV (regimen 1). The 35% (7/20)
responded to it and passed products of conception. The
remaining 65% (13/20) were offered further three PV doses
of 400mcg misoprostol 3 hours apart from each (regimen
2). However some patients (3/13) in the later group did not
respond and as a result required surgical evacuation of RPOC.
None of the patients on expectant/medical management
in our study needed (opiate) analgesia/antibiotics or blood
transfusion. All the patients attended their planned follow-up
(Figure 1).
5. Discussion
Before the publication of NICE Guideline 154, we used to
offer conservative, medical, or surgical management options
to the patients after confirming the diagnosis of miscarriage
assuming that all are equally effective and no one is superior
to other as seen by a Cochrane review by Nanda et al. [2].
In that review, they concluded that expectant and surgical
management are equally effective and the women preference
should be taken into consideration.
It is arguable that recruitment of women for trial involv-
ing expectant management may not be easy because “wait-
and-see approach” for one or two weeks sometimes is
not an acceptable option for women after the diagnosis
of miscarriage. There are few published RCTs [3, 4], that
recruited women for comparison of expectant, medical, and
surgical management of miscarriage. The number of patients
recruited for expectant management in MIST trial [3] was
398/802 whereas Shelley et al. [4] managed to recruit 40
women in their trial.
As there are not many RCTs comparing expectant versus
medical versus surgical treatment therefore,we have to rely
on the available data from the observational studies which
showed variable success rate with expectant management
in incomplete miscarriage ranges from 79 to 96% [5] and
25 to 85% [6] in missed miscarriage. A longitudinal study
conducted byP. Schwärzler et al. [7] reported 62% success rate
after two weeks of expectant management of missed miscar-
riage or anembryonic pregnancy. In this study, 85/108 women
opted for expectant management. A similarly longitudinal
observational study by Casikar et al. [8] reported overall 61%
(124/203) success rate.
The two weeks’ time frame for the expectant or conser-
vative management of miscarriage is also questionable as we
can find reports in literature that relate higher success rate
with longer duration up to 6–8 weeks [9]. In this context, the
most recent prospective study published in November 2013
by Al-Ma’ani et al. (expectant versus surgical management)
recruited 109 women in expectant group and quoted 81.4%
success rate with 4-week wait [10].
In our study, the 58% success rate after two weeks of con-
servative management is not different from the above men-
tioned studies. As the criteria for ultrasound scan findings of
incomplete miscarriage or the presence of retained products
at follow-up vary widely therefore, it is understandable to
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Figure 1: Result summary. Regimen 1: misoprostol loading dose of 800mcg followed by 400mcg per vagina after 6 hours. Regimen 2: further
three doses of 400mcg misoprostol (3 hours apart) per vagina if there is no response to regimen 1.
expect different success rate reported in different studies [3].
In our study, both clinical and ultrasound findings were used
for outcome measure. We can argue that the reported higher
success rate in some studies is seen when follow-up is based
on clinical findings rather than based on ultrasound [11].
It is a common observation that anxiety of emotional or
psychological stress is associated with miscarriage that may
be more with “wait-and-see approach” in the absence of sup-
portive counselling. Therefore we particularly emphasized
this aspect while recruiting the patients in our study. There
is no significant difference in pain, physical recovery, anxiety,
or emotional disturbances between medical versus expectant
management [12] and also for surgical versus expectant
management [13].
6. Limitations
Though this was a noncomparative longitudinal study in
which number of patients was relatively more as compared
to many other observational studies published so far. Our
follow-up rate was 100% and we believed that it was due
to supportive counselling and a follow-up appointment on
D14 with ultrasound scan was booked at the commencement
of expectant management. However women were advised to
report us if they had completemiscarriage with the resolution
of symptoms during that two-week period. All outcomes
of our study were documented in clinical notes. Our study
showed good acceptance rate for conservative management.
We believed that good counselling and explanation can
overcome the problem of recruiting women for clinical trials
or comparative studies for the management of miscarriage as
faced by authors of various studies referred in the above text.
7. Conclusion
Our study showed that the expectant management success
rate is consistent with the results published in longitudinal
studies and RCTs conducted so far, before NICE Guideline
154 was available. It is a safe option with significant success
rate and minimal requirement for opiate analgesia, antibi-
otics, or blood transfusion. The majority of the cases can be
managed in community without the need for hospitalization.
In our unit, it helped to establish nurse lead services and
utilization of beds for elective gynaecology workload.
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